-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Armata Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- Armata Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.48M, a 82.4% increase year-over-year.
- Armata Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$41.4M, a 30.5% increase year-over-year.
- Armata Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$69M, a 87% decline from 2022.
- Armata Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.9M, a 59.4% decline from 2021.
- Armata Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$23.2M, a 4.39% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)